Medtronic (NYSE:MDT) is a global medical technology company specializing in the development, manufacture and distribution of devices and therapies to treat a broad range of chronic diseases. Its primary business segments include Cardiac and Vascular, which offers pacemakers, stents and heart valves; Minimally Invasive Therapies, encompassing surgical instruments and respiratory care products; Restorative Therapies, featuring spinal and neuromodulation systems; and Diabetes, providing insulin pumps and continuous glucose monitoring solutions.
Founded in 1949 by Earl Bakken and Palmer Hermundslie as a medical equipment repair shop in Minneapolis, Medtronic introduced its first wearable external pacemaker in the early 1950s, setting the stage for decades of innovation in cardiac care. Over time, the company expanded its product portfolio through both internal research and development and strategic acquisitions, positioning itself as a pioneer in implantable devices and minimally invasive surgical technologies.
While incorporated in Ireland following its merger with Covidien in 2015, Medtronic maintains its operational headquarters in Dublin and its executive and R&D centers in Fridley, Minnesota. The company serves hospitals, physician offices and ambulatory surgical centers in more than 150 countries across North America, Europe, Asia-Pacific, Latin America and the Middle East. Its global footprint is supported by manufacturing sites, research facilities and customer support operations worldwide.
Under the leadership of Chief Executive Officer Geoff Martha, who assumed the role in 2020, Medtronic continues to focus on expanding access to advanced medical therapies and investing in digital health and remote monitoring solutions. The company’s executive team draws on a breadth of experience in healthcare, engineering and life sciences to drive innovation and improve patient outcomes across its diverse portfolio of products and services.
